risedronic acid has been researched along with Renal Insufficiency in 2 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Renal Insufficiency: Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "etidronate) have been associated with acute renal failure." | 2.44 | Safety considerations with bisphosphonates for the treatment of osteoporosis. ( Civitelli, R; Emkey, R; Strampel, W, 2007) |
| "To develop a population pharmacokinetic model that describes the absorption and low plasma levels of risedronate in the body." | 1.62 | Osteoporosis treatment with risedronate: a population pharmacokinetic model for the description of its absorption and low plasma levels. ( Cardozo, B; Karalis, V; Karatza, E, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cardozo, B | 1 |
| Karatza, E | 1 |
| Karalis, V | 1 |
| Strampel, W | 1 |
| Emkey, R | 1 |
| Civitelli, R | 1 |
1 review available for risedronic acid and Renal Insufficiency
| Article | Year |
|---|---|
Safety considerations with bisphosphonates for the treatment of osteoporosis.
Topics: Acute-Phase Reaction; Administration, Oral; Alendronate; Bone Density Conservation Agents; Diphospho | 2007 |
1 other study available for risedronic acid and Renal Insufficiency
| Article | Year |
|---|---|
Osteoporosis treatment with risedronate: a population pharmacokinetic model for the description of its absorption and low plasma levels.
Topics: Administration, Oral; Cross-Over Studies; Humans; Models, Biological; Osteoporosis; Renal Insufficie | 2021 |